We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AMAT:NASDAQApplied Materials, Inc. Analysis

Data as of 2026-03-09 - not real-time

$334.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Applied Materials is riding a clear uptrend with the short‑term moving averages positioned above longer‑term averages, and the price comfortably above the nearest support level. The RSI sits near the mid‑range, indicating no immediate overbought pressure, while the MACD has turned bearish, suggesting a short‑term pullback may be ahead. Volatility remains elevated and beta is high, reflecting pronounced price swings, yet the company’s profitability metrics—exceptional ROE, solid operating margins, and strong cash generation—remain robust. Recent earnings have beaten expectations, and the guidance for the next quarter exceeds consensus, reinforcing confidence in the earnings trajectory.
Valuation appears attractive: the discounted cash‑flow model signals upside, forward earnings multiples have compressed, and analyst price targets sit well above the current level, implying the stock is undervalued relative to its growth prospects. The modest dividend yield is backed by a low payout ratio and ample cash, supporting sustainability. While sector cyclicality and geopolitical exposure introduce medium‑level risks, the overall risk profile is manageable, leading to a bullish stance for the medium and long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD momentum suggests limited upside in the near term
  • Price is above key support, reducing downside risk
  • High volatility may cause short‑term price swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Earnings beat and guidance above expectations
  • Undervalued relative to DCF and analyst targets
  • Strong cash position and low debt‑to‑equity ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained high ROE and operating margins
  • Industry tailwinds from new chip fab investments
  • Dividend sustainability with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth-2.10%
Profit Margin27.78%
P/E Ratio34.3
ROE38.86%
ROA14.85%
Debt/Equity33.11
P/B Ratio12.2
Op. Cash Flow$8.7B
Free Cash Flow$4.3B
Industry P/E36.7

Technical Analysis

TrendBullish
RSI45.8
Support$316.10
Resistance$395.95
MA 20$356.89
MA 50$324.66
MA 200$232.29
MACDBearish
VolumeDecreasing
Fear & Greed Index100

Valuation

Fair Value$77.52
Target Price$410.63
Upside/Downside22.82%
GradeUndervalued
TypeBlend
Dividend Yield0.57%

Risk Assessment

Beta1.70
Volatility58.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.